All News

Toxicities and limitations of CAR therapy: the other side of its incredibly exciting, boundless potential @Michel_Sadelain @MSKCancerCenter #ACR23 @RheumNow https://t.co/L1UIqqlOdC
David Liew drdavidliew ( View Tweet)
Congrats to Dr Kaitlin McCarter for her #ACR23 investigating predictors and mortality of pre-existing RA flare after immune checkpoint inhibitor. 46% flared Seropositive- OR 2.0 NO association with mortality -ICIs are safe to use in RA -Flares are not a proxy of efficacy https://t.co/eoy0FJb1nA
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
Conundrum of #Clinically #Quiescent #Serologically #Active #SLE-half flare within 5 yrs; can have organ damage. Large cohort-China 20% met def’n- diff trajectories 37% flare 1/6 got damage in f/u Some tapered Rx How to identify safe to d/c Rx? 2555 #ACR23 @ACRheum @RheumNow https://t.co/f49BQspQsz
Janet Pope  ( View Tweet)
Are all ICI-IA irAEs the same? @cappelliMD @jhrheumatology presented lovely work: latent class analysis on her cohort data She found two phenotypes - one with more persistent symptoms, & potentially a start in stratifying irAE therapy going forward. #ACR23 ABST2513 @RheumNow https://t.co/roW00KwbVZ
David Liew drdavidliew ( View Tweet)
Patella tendon characteristics with USG - thickness, cross sectional area and stiffness measures with shear wave elastography In pts with or without knee pain @rheumnow #ACR23 52 pts Pain didnt correralate with thick ess and cross sectional area but did correlate with stiffness https://t.co/q3ZPG1l2n2
Bella Mehta bella_mehta ( View Tweet)
Plenary Abs #2425: Pregnancies among vasculitis pts - higher frequency of spontaneous abortion and preterm delivery. Risk of maternal complications associated with vasculitis were observed to vary by vessel size and parity. #ACR23 https://t.co/qLcpNapcjg @rheumnow https://t.co/sk3dhySVfP
Dr. Rachel Tate  ( View Tweet)
LNK01001 12 mg or 24 mg BID to 24 weeks in moderate to severe RA achieved ACR 20 (91.1%, 90.7% respectively), were generally safe, well tolerated with most TEAEs being mild to moderate. Effect seen in Week 1. Wu C, Late breaking Abst#L09 #ACR23 @RheumNow https://t.co/M29LYtEs9I

Dr. Antoni Chan  ( View Tweet)

AutoAb and irAE?? Really only associated for thyroid dysfunction. For ICI-IA we need different bio markers #ACR23 https://t.co/Fc24y8TzJv
Laura Cappelli  ( View Tweet)
Congratulations to Mount Sinai medical student and mentee Celestine He, on being awarded a Rheumatology Research Foundation Medical Student Preceptorship Award. Very proud of you and your excellent work! 👏🏻👏🏻👏🏻 #ACR23 @celestinejhe @MSRheumatology @IcahnMountSinai https://t.co/F078eSnL9p
Chrisanna Dobrowolski  ( View Tweet)
Our collaborative study on nirmatrelvir-ritonavir (Paxlovid) virologic rebound is out in @AnnalsofIM @DrJLi @zach_wallace_md -Paxlovid: 21% with rebound vs. 2% in untreated (OR 10) https://t.co/RRDxerGdBy

Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)

US adults with #gout had higher 10-year all-cause mortality rates than those without Premature mortality in gout ➡️Has not improved over time despite improved survival in the general population ➡️Worse among women ➡️Worse among Black individuals #ACR23 👉🏽https://t.co/NDCIhKfCNL https://t.co/uKCswHKU0n
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Hanging w a super star ⭐️ @CCalabreseDO https://t.co/yDcAMAr24V

Leonard Calabrese LCalabreseDO ( View Tweet)

It's the fab @AurelieRheumo 🎉 https://t.co/ywp9uPC5yl

Beth  ( View Tweet)

https://t.co/ft1wNmMxGx

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
So great to see posters back at #ACR23 and interactions of #students and #mentors which can be career shaping. Data from #Alberta with a nearly 3K survey on #cannabis use in Pts with #rheumatic diseases studying the use as #Rx and #recreational @RheumNow #979, 980 https://t.co/xbVcK5HuRS
Janet Pope  ( View Tweet)
#Exercise reduces #pain in knee #osteoarthritis ▶️Improvement at weeks 6 & 12, sustained at week 18 #ACR23 poster 1990 👉🏽https://t.co/y4quoWG5Hi by @ProfDeepakKumar et al https://t.co/zbf05FCLZ9
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
#ACR23 Abs #L07 data do not support tapering of TNFi treatment among RA patients in sustained remission in 3 year study. https://t.co/d0ZBWDKZlB https://t.co/EdllyGUT1y
Dr. Rachel Tate  ( View Tweet)
Anyone have any insight on the number of missing virtual posters #ACR23 ? Is it simply that people did not submit one by the deadline?

Richard Conway  ( View Tweet)

Dr. Sadelain gives a tour-de-force CAR-T overview for the future. Questions around programming antigen sensitivity and the life span of therapy are just the tip of the iceberg. #ACR23 @RheumNow https://t.co/oLog0SiQoE
Dr. Rachel Tate  ( View Tweet)
Rx of #inflammatory #arthritis with #glucocorticoids doesn’t seem to affect outcomes in #malignancy treated with #checkpoint #inhibitors. Good news as new or flaring inflammatory arthritis as an irAE can be severe. #ACR23 @RheumNow @ACRheum #1055 @CanRIO_Tweets https://t.co/tFIPcQq2X6
Janet Pope  ( View Tweet)
×